Loading...
Botanix Pharmaceuticals Limited
BXPHF•PNK
Healthcare
Biotechnology
$0.14
$0.00(0.00%)
Botanix Pharmaceuticals Limited (BXPHF) Financial Performance & Income Statement Overview
Review Botanix Pharmaceuticals Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-34.23%
↓ 34.23%
Operating Income Growth
-14.88%
↓ 14.88%
Net Income Growth
-51.52%
↓ 51.52%
Operating Cash Flow Growth
32.69%
↑ 32.69%
Operating Margin
-693.76%
↓ 693.76%
Gross Margin
-193.64%
↓ 193.64%
Net Profit Margin
-670.20%
↓ 670.20%
ROE
-18.00%
↓ 18.00%
ROIC
-13.20%
↓ 13.20%
Botanix Pharmaceuticals Limited (BXPHF) Income Statement & Financial Overview
Review Botanix Pharmaceuticals Limited's (BXPHF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.69M | $377930.00 | $526976.00 | -$142531.00 |
| Cost of Revenue | $2.67M | $3.40M | $2.71M | $146161.00 |
| Gross Profit | -$982433.00 | -$3.02M | -$2.19M | -$288692.00 |
| Gross Profit Ratio | -$0.58 | -$8.004 | -$4.15 | $2.03 |
| R&D Expenses | $834730.00 | $978208.00 | $636670.00 | $318335.00 |
| SG&A Expenses | $7.01M | $1.52M | $1.69M | $1.43M |
| Operating Expenses | $7.85M | $2.50M | $2.33M | $2.01M |
| Total Costs & Expenses | $10.52M | $5.90M | $5.04M | $2.16M |
| Interest Income | $34162.00 | $41559.00 | $46946.00 | $20941.00 |
| Interest Expense | $4032.00 | $6627.00 | $5064.00 | $0.00 |
| Depreciation & Amortization | $64176.00 | $8431.00 | $93606.00 | $5217.00 |
| EBITDA | -$8.40M | -$5.52M | -$2.25M | -$2.25M |
| EBITDA Ratio | -$4.97 | -$14.60 | -$8.39 | $15.80 |
| Operating Income | -$8.83M | -$5.53M | -$4.51M | -$2.26M |
| Operating Income Ratio | -$5.22 | -$14.62 | -$8.57 | $15.84 |
| Other Income/Expenses (Net) | -$1.04M | $59146.00 | -$141828.00 | -$141828.00 |
| Income Before Tax | -$9.87M | -$5.47M | -$4.56M | -$2.28M |
| Income Before Tax Ratio | -$5.83 | -$14.47 | -$8.65 | $15.99 |
| Income Tax Expense | -$1.47M | -$1.00 | $4.00 | $0.00 |
| Net Income | -$8.40M | -$5.47M | -$4.56M | -$2.28M |
| Net Income Ratio | -$4.97 | -$14.47 | -$8.65 | $15.99 |
| EPS | -$0.005 | -$0.004 | -$0.004 | -$0.002 |
| Diluted EPS | -$0.005 | -$0.004 | -$0.004 | -$0.002 |
| Weighted Avg Shares Outstanding | $1.56B | $1.44B | $1.31B | $1.29B |
| Weighted Avg Shares Outstanding (Diluted) | $1.56B | $1.44B | $1.31B | $1.29B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan